TO THE EDITOR: With great interest we have read the article by Wang and colleagues recently published in this journal (26). Wang et al. describe a method to assess glucose production rates in rodents from the kinetics of an IP injected glucose tracer, i.e., U-13 C-glucose. The authors compared IV and IP injection protocols in rats and mice and demonstrated anticipated outcomes after treatment of fZDFf rats and ob/ob mice with PPAR␥ agonists . Their method compared satisfactorily with the "gold standard" approach to assess insulin sensitivity of glucose production, i.e., the euglycemic hyperinsulinemic clamp. It is concluded that ". . .it is possible to (i) quantify glucose production using an intraperitoneal injection of tracer and (ii) derive a "glucose production index" by coupling estimates of basal glucose production with measurements of fasting insulin concentration; this yields a proxy for clampderived assessments of insulin sensitivity of endogenous production."
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We were particularly interested in this work since our laboratory has gone through a similar sequence of experimental developments during the past 15 years. For quantification of relevant fluxes of glucose metabolism in unanesthetized rodents we have adapted the mass isotopomer distribution analysis (MIDA) approach developed by Hellerstein et al. (e.g., Refs. 7-9, 14, and 15) using permanent jugular vein catheters for continuous infusion of tracers. Studies were performed in rats (25) and, after adjustments to allow for bloodspot and urine collections on filter paper, also in mice (24) . We have successfully demonstrated effects of feeding state (3, 4, 18, 24) , enzyme deficiencies (5, 10, 11), metabolic manipulations (1, 2, 17) , and drugs (13, 16, 25) on the various pathways of glucose metabolism. By applying a double-inlet catheter, we also performed euglycemic hyperinsulinemic clamp studies in unanesthetized mice (6, 13, 21) . Although highly informative, procedures are labor-intensive and multiple tests in individual mice cannot be performed. Therefore, we developed and published (12, 19, 22, 23) an alternative method for this purpose, apparently unnoticed by Wang and colleagues (26) .
Our solution also involved IP injection of a small amount of a stable isotopically labeled glucose that does not affect blood glucose concentrations, after which glucose kinetic parameters are determined by modeling under the assumption that the kinetics can be described by a single pool model (23) . The time course of tracer concentration in blood can adequately be described by a biexponential curve, of which the first describes the efflux and the second the influx of the tracer. Using SAAM II (The Epsilon Group, Charlottesville, VA), the curves are fitted to the data. The estimated parameters are then used to calculate relevant kinetic parameters describing blood glucose metabolism. Key parameters such as bioavailability and apparent volume of distribution are calculated for every situation rather than estimated as done by Wang et al. (26) . Importantly, we use bloodspot sampling from the tail-tip on filter paper to reduce blood loss (total amount~120 l/mouse). Several studies applying this method have been published (12, 19, 22) , showing its applicability even in frail mice (22) in which surgery is not possible. This method allows for repeated measures in individual animals and hence contributes to the societal quest to reduce numbers of experimental animals in biomedical research. Importantly, the concept appears to be translatable to humans upon oral intake of a small amount of [6, H 2 ]glucose (van Dijk TH, Jalving H. Kuipers F, unpublished observations): initial experiments in healthy volunteers showed that kinetic parameters derived from both venous blood draws and fingertip bleeding were highly similar to those obtained by invasive techniques (20, 27) . Thus this method is promising for use in longitudinal studies in humans. 
